Innate Pharma SA Key Management Personnel Compensation Postemployment Benefits
Innate Pharma SA (IPHA) reported Key Management Personnel Compensation Postemployment Benefits of EUR 107.00 thousand for the 6-month period ending 2025-06-30, per its 6-K filed 2025-09-17.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits · last filed 2025-09-17
| Period end | Key Management Personnel Compensation Postemployment Benefits 6 month | Key Management Personnel Compensation Postemployment Benefits 12 month |
|---|---|---|
| 2025-06-30 | 107.00K EUR 6-K · filed 2025-09-17 | |
| 2024-12-31 | 166.00K EUR 20-F · filed 2025-04-30 | |
| 2024-06-30 | 21.00K EUR 6-K · filed 2025-09-17 | |
| 2023-12-31 | 33.00K EUR 20-F · filed 2025-04-30 | |
| 2023-06-30 | 11.00K EUR 6-K · filed 2024-09-12 | |
| 2022-12-31 | 43.00K EUR 20-F · filed 2025-04-30 | |
| 2022-06-30 | 11.00K EUR 6-K · filed 2023-09-14 | |
| 2021-12-31 | 11.00K EUR 20-F · filed 2024-04-04 | |
| 2021-06-30 | 0.00 EUR 6-K · filed 2022-09-15 | |
| 2020-12-31 | 0.00 EUR 20-F · filed 2023-04-06 | |
| 2020-06-30 | 0.00 EUR 6-K · filed 2021-09-15 | |
| 2019-12-31 | 12.00K EUR 20-F · filed 2022-04-04 | |
| 2018-12-31 | 12.00K EUR 20-F · filed 2021-04-27 | |
| 2017-12-31 | 12.00K EUR 20-F · filed 2020-04-24 |